Concentrix (NASDAQ:CNXC) Rating Lowered to “Hold” at Wall Street Zen

Concentrix (NASDAQ:CNXC) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday.

A number of other brokerages have also recently commented on CNXC. Robert W. Baird dropped their price target on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research report on Wednesday, March 25th. Weiss Ratings cut Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Canaccord Genuity Group dropped their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, March 25th. Finally, Barrington Research cut their target price on Concentrix from $62.00 to $38.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $48.50.

Concentrix Stock Performance

Shares of CNXC stock opened at $26.42 on Friday. The company’s fifty day moving average price is $34.38 and its 200-day moving average price is $39.78. The stock has a market cap of $1.62 billion, a PE ratio of -1.23, a price-to-earnings-growth ratio of 0.33 and a beta of 0.50. The company has a current ratio of 1.18, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43. Concentrix has a 12 month low of $24.27 and a 12 month high of $64.74.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.65 by ($0.04). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The business had revenue of $2.50 billion during the quarter, compared to the consensus estimate of $2.49 billion. During the same quarter in the previous year, the business earned $2.79 earnings per share. The firm’s revenue was up 5.4% compared to the same quarter last year. On average, equities analysts expect that Concentrix will post 10.11 EPS for the current fiscal year.

Insiders Place Their Bets

In other Concentrix news, CEO Christopher A. Caldwell acquired 1,000 shares of the stock in a transaction that occurred on Thursday, January 29th. The shares were acquired at an average cost of $37.07 per share, with a total value of $37,070.00. Following the transaction, the chief executive officer owned 362,075 shares of the company’s stock, valued at $13,422,120.25. The trade was a 0.28% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.90% of the stock is currently owned by insiders.

Institutional Trading of Concentrix

A number of institutional investors and hedge funds have recently modified their holdings of CNXC. Royal Bank of Canada boosted its position in shares of Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after buying an additional 4,133 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Concentrix by 75.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after buying an additional 181,546 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock worth $8,152,000 after buying an additional 21,746 shares during the last quarter. Focus Partners Wealth bought a new position in Concentrix during the 1st quarter valued at about $781,000. Finally, Geneos Wealth Management Inc. lifted its stake in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares during the period. Institutional investors own 90.34% of the company’s stock.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Management emphasized AI-led growth opportunities on the Q1 earnings call and highlighted strategic initiatives that could boost margins over time. Concentrix Earnings Call Highlights AI-Led Growth
• Neutral Sentiment: Q1 revenue came in roughly in line or slightly above expectations and grew year-over-year, showing demand resilience even as profitability disappointed; the full earnings-call transcript is available for detail on guidance and cost actions. Concentrix Q1 2026 earnings call transcript
• Neutral Sentiment: Several market roundups listed CNXC among stocks trading down after the print, reflecting broad market reaction rather than company-specific news only. Driven Brands, Cogent, Concentrix, Arlo Technologies, and Planet Labs Stocks Trade Down
• Negative Sentiment: CNXC missed on EPS (market coverage highlights a sizable EPS miss in headlines), which is the primary driver of the selloff as investors punish the near-term profitability miss. Concentrix Corporation Just Missed EPS By 63%
• Negative Sentiment: Multiple brokerages lowered expectations and issued pessimistic forecasts/price-target cuts following the quarter (Barrington Research, Robert W. Baird, Canaccord Genuity), increasing sell-side pressure. Barrington Research Has Lowered Expectations for Concentrix
• Negative Sentiment: Coverage pieces report shares falling and CNXC hitting a new one-year low after the earnings miss, a sign of quantitatively increased downside interest and weaker near-term sentiment. Concentrix Sets New 1-Year Low After Earnings Miss
• Negative Sentiment: News outlets summarized the stock decline as “disappointing earnings” with shares down several percent, reinforcing the negative momentum. Shares Down on Disappointing Earnings

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.